YAKUGAKU ZASSHI
Online ISSN : 1347-5231
Print ISSN : 0031-6903
ISSN-L : 0031-6903
一般論文
テルグリドの高プロラクチン血症治療効果のドパミンD2受容体結合占有を考慮したPK/PD解析
山田 安彦入月 直子高柳 理早山本 健次郎澤田 康文伊賀 立二
著者情報
ジャーナル フリー

2003 年 123 巻 4 号 p. 255-260

詳細
抄録

Terguride has been widely used for the treatment of hyperprolactinemia via partial agonistic action on dopamine D2 receptors in the pituitary. The present study analyzed retrospectively the dopamine D2 receptor binding occupancy (Φ) of terguride. The average Φ value was estimated to be 14.1% after oral administration of the average/standard therapeutic dose of terguride. Taking the intrinsic activity (α) into consideration, the value of α · Φ was 2.33%. These results suggest that the antihyperprolactinemic effect of terguride was elicited despite the low receptor occupancy. Furthermore, we developed a pharmacokinetic/pharmacodynamic model for ascertaining the serum prolactin-lowering effect of terguride, considering both the reversible binding to D2 receptors and the effect on the increase rate in the prolactin level. The developed model fit well with the actual data. Although this model could be improved, it could explain the long duration of the antihyperprolactinemic activity of terguride and might be useful for designing its rational dosage regimen.

著者関連情報
© 2003 by the PHARMACEUTICAL SOCIETY OF JAPAN
前の記事 次の記事
feedback
Top